Why the study?
Frequent exacerbations of bronchiectasis impair lung function and increase mortality, prompting an evaluation of risk factors for readmission within one year.
What are the risk factors for readmission within one year after acute exacerbation of bronchiectasis?
What are the risk factors for readmission within one year after acute exacerbation of bronchiectasis?
Chronic Pseudomonas aeruginosa colonization and other clinical factors increase the risk of 1-year readmission in bronchiectasis patients, while long-term oral antibiotics decrease it.
May inform post-discharge monitoring in bronchiectasis; leaves open whether intervening on identified risk factors reduces readmissions.
BACKGROUND: Frequent exacerbations of bronchiectasis lead to poor quality of life, impaired lung function, and higher mortality rates. This study aims to evaluate the risk factors associated with readmission within one year due to acute exacerbation of bronchiectasis (AEB). METHODS: A retrospective cohort study was performed on 260 patients with bronchiectasis who were hospitalized in the respiratory and critical care department of a tertiary hospital in China. Univariate and multivariate Cox analyses were used to evaluate the risk factors for readmission within one year. RESULTS: (HR = 1.71; 95% CI: 1.16 to 2.51), respiratory intensive care unit (RICU) stay during admission (HR = 2.06, 95% CI: 1.16-3.67), involvement of 3 or more lobes on chest high-resolution computed tomography (HRCT) (HR = 1.85; 95% CI, 1.22 to 2.80), chronic Pseudomonas aeruginosa (PA) colonization (HR = 2.29; 95% CI: 1.54 to 3.38), and positive sputum culture results within 24 h after admission (HR = 1.93; 95% CI: 1.27 to 2.94). Long-term oral antibiotics use after discharge was associated with decreased hazard of readmission (HR = 0.34; 95% CI: 0.20 to 0.59). CONCLUSIONS: Patients with bronchiectasis have a high rate of readmission, which is linked to varieties of risk factors, and identifying these risk factors is importance for effectively managing patients with bronchiectasis.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: